Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,031.60
(
-2.05%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.75
(
1.07%
)
Bitcoin
68,587.00
(
-0.29%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2637
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: jq1234 post# 179093

Wednesday, 06/11/2014 8:04:43 AM

Wednesday, June 11, 2014 8:04:43 AM

Post# of 257295
RCPT

Slide 7* confirms that Tysabri is the BIC for reducing relapses in RRMS with a 67% reduction.

On Tysabri my wife went about 5 years without an attack or any evidence of new injury per gd-MRI. (Switched her to Tecfidera due to JCV+)




* RMS Clinical Efficacy Outcomes
Comparison of Reduction in Annualized Relapse Rate (ARR)

It is astonishing what foolish things one can temporarily believe if one thinks too long alone ... where it is often impossible to bring one's ideas to a conclusive test either formal or experimental. J.M. Keynes

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today